MiMedx Group Dividends and Buybacks

Dividend criteria checks 0/6

MiMedx Group does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.05%

Buyback Yield

Total Shareholder Yield0.05%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

We Ran A Stock Scan For Earnings Growth And MiMedx Group (NASDAQ:MDXG) Passed With Ease

Nov 21
We Ran A Stock Scan For Earnings Growth And MiMedx Group (NASDAQ:MDXG) Passed With Ease

There's No Escaping MiMedx Group, Inc.'s (NASDAQ:MDXG) Muted Earnings Despite A 27% Share Price Rise

Nov 06
There's No Escaping MiMedx Group, Inc.'s (NASDAQ:MDXG) Muted Earnings Despite A 27% Share Price Rise

MiMedx Group, Inc.'s (NASDAQ:MDXG) Shares Bounce 27% But Its Business Still Trails The Industry

May 21
MiMedx Group, Inc.'s (NASDAQ:MDXG) Shares Bounce 27% But Its Business Still Trails The Industry

We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt

May 14
We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt

Improved Revenues Required Before MiMedx Group, Inc. (NASDAQ:MDXG) Shares Find Their Feet

Mar 27
Improved Revenues Required Before MiMedx Group, Inc. (NASDAQ:MDXG) Shares Find Their Feet

We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt

Jan 05
We Think MiMedx Group (NASDAQ:MDXG) Can Stay On Top Of Its Debt

MiMedx Group, Inc. (NASDAQ:MDXG) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Dec 18
MiMedx Group, Inc. (NASDAQ:MDXG) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Is MiMedx Group (NASDAQ:MDXG) Using Debt In A Risky Way?

Aug 08
Is MiMedx Group (NASDAQ:MDXG) Using Debt In A Risky Way?

Does MiMedx Group (NASDAQ:MDXG) Have A Healthy Balance Sheet?

Apr 22
Does MiMedx Group (NASDAQ:MDXG) Have A Healthy Balance Sheet?

Health Check: How Prudently Does MiMedx Group (NASDAQ:MDXG) Use Debt?

Dec 20
Health Check: How Prudently Does MiMedx Group (NASDAQ:MDXG) Use Debt?

MiMedx gets Japanese reimbursement approval for its tissue allograft EPIFIX

Sep 12

MiMedx Group expects AWC full-year sales in low end of 11%-14% growth range

Sep 06

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MDXG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MDXG's dividend payments have been increasing.


Dividend Yield vs Market

MiMedx Group Dividend Yield vs Market
How does MDXG dividend yield compare to the market?
SegmentDividend Yield
Company (MDXG)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.3%
Industry Average (Biotechs)2.3%
Analyst forecast (MDXG) (up to 3 years)n/a

Notable Dividend: Unable to evaluate MDXG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MDXG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate MDXG's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MDXG has not reported any payouts.


Discover strong dividend paying companies